Results 91 to 100 of about 57,515 (295)

Neonatal BCG Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial

Allergy, EarlyView.
Laure F. Pittet, Nicole L. Messina, Kate L. Francis, Susan Donath, Katie L. Flanagan, Emily K. Forbes, Kaya Gardiner, Roderic J. Phillips, Anne‐Louise Ponsonby, Roy Robins‐Browne, Frank Shann, Mike South, Peter Vuillermin, Dan Casalaz, Nigel Curtis, On the behalf of the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR) Group   +15 more
wiley   +1 more source

Anticipating Knowledge Applicability in Open Science Through Recycling, Mimicking, and Shortcutting

R&D Management, EarlyView.
ABSTRACT Open science literature scrutinizes how organizations provide access to knowledge. Yet, much less is known about how organizations pursuing open science for societal impact anticipate knowledge applicability—that shared knowledge is reusable for other organizations and individuals, and enables open social innovation.
Konstantin Hondros, Milena Leybold, Leonhard Dobusch, Sigrid Quack   +3 more
wiley   +1 more source

BCG re-vaccination [PDF]

Thorax, 2001
The most recent guidelines on the control and prevention of tuberculosis1 recommend that “individuals working as health care workers, irrespective of age, who are previously unvaccinated and who are negative or Heaf grade 1 on tuberculin testing, should receive BCG vaccination”.
openaire   +3 more sources

Which Care‐Seekers are Prioritized for Preventive Maternal and Child Health Services in a Low‐Resource Setting? A Vignette Experiment in Rural Guinea‐Bissau

Tropical Medicine &International Health, EarlyView.
ABSTRACT Objectives Human resource shortages create bottlenecks to preventive maternal and child health service provision in low‐resource settings, making ad‐hoc service rationing at the point of care necessary. Little is known about how healthcare providers prioritise.
Anne‐Sophie Sparresø Bærentzen, Kimberly Raisa Nehal, Demba Pedro Gomes, Stéphane Helleringer, Ane Bærent Fisker, Sabine Margarete Damerow   +5 more
wiley   +1 more source

Tuberculosis vaccine: pipeline approaches and future prospective [PDF]

, 2011
Tuberculosis (TB), despite anti-mycobacterial therapies and vaccine, is a deadly infectious disease with about 12 million incident cases worldwide. Existing Bacillus Calmette-Guérin (BCG) vaccine is unquestionably inexpensive, safe and effective ...
Ankita Singh, L K Dwivedi, Poonam Yadav   +2 more
core   +2 more sources

The influence of BCG on vaccine responses – a systematic review

Expert Review of Vaccines, 2018
Introduction: Bacillus Calmette-Guérin (BCG) vaccine is one of the most widely used vaccines worldwide. In addition to providing protection against tuberculosis, it has non-specific (heterologous) immunomodulatory effects.
Petra Zimmermann, Nigel Curtis
doaj   +1 more source

World Association for Veterinary Dermatology Consensus Statement for Diagnosis, and Evidence‐Based Clinical Practice Guidelines for Treatment and Prevention of Canine Leishmaniosis

Veterinary Dermatology, EarlyView.
Hyperkeratosis of (a) the footpads and (b) the nasal planum. ABSTRACT Background Canine leishmaniosis (CanL) due to Leishmania infantum remains common, and veterinarians do not always follow scientifically sound approaches for diagnosis, treatment and prevention. Objectives To provide consensus guidelines for diagnosis and evidence‐based guidelines for
Manolis N. Saridomichelakis, Gad Baneth, Silvia Colombo, Filipe Dantas‐Torres, Lluís Ferrer, Alessandra Fondati, Guadalupe Miró, Laura Ordeix, Domenico Otranto, Chiara Noli   +9 more
wiley   +1 more source

Culturally Responsive Surgical Care for Older People and Family Carers: A Dyadic Analysis

Nursing &Health Sciences, Volume 27, Issue 4, December 2025.
ABSTRACT The aim of this article is to explore the perspectives and experiences of ethnically diverse older patients and family carers when undergoing a surgical procedure. Exploratory qualitative research design. Semi‐structured interviews with six patient‐carer dyads and three individuals, totaling 15 participants.
Charmaine G. Bonus, Deborah Hatcher, Jed Montayre   +2 more
wiley   +1 more source

Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? [PDF]

, 2005
Tuberculosis vaccine candidates are entering clinical studies in areas where BCG fails. This is a high-risk strategy. We suggest that geographical variation in the efficacy of BCG is related to the presence in developing countries of a cross-reactive ...
Dheda, K, Rook, GAW, Zumla, A
core   +1 more source

The whole genome sequence of Polish vaccine strain Mycobacterium bovis BCG Moreau

Microbiology Spectrum
Currently, tuberculosis immunoprophylaxis is based solely on Bacillus Calmette-Guérin (BCG) vaccination, and some of the new potential tuberculosis vaccines are based on the BCG genome. Therefore, it is reasonable to analyze the genomes of individual BCG
Katarzyna Krysztopa-Grzybowska, Jakub Lach, Maciej Polak, Dominik Strapagiel, Jaroslaw Dziadek, Marcin Olszewski, Aleksandra A. Zasada, Aniela Darlińska, Anna Lutyńska, Ewa Augustynowicz-Kopeć   +9 more
doaj   +1 more source